Related Experiment Video
Updated: May 30, 2025

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
Published on: April 21, 2019
The global prevalence of reported penicillin allergy: A systematic review and meta-analysis
Akish Luintel1, Joseph Healy2, Michael Blank2
1Institute of Global Health Innovation, Imperial College London, UK.
Objectives:
Patients labelled with penicillin allergy (PenA) often receive broader spectrum antibiotics, associated with antimicrobial resistance and poorer outcomes. However, ∼95% of patients are likely mis-labelled. Whilst de-labelling programmes are gaining momentum, they have been restricted to a few countries. Here, we address the global prevalence of PenA, to inform the wider potential impact for de-labelling programmes.
Methods:
We conducted a systematic review and meta-analysis including all studies on adult PenA prevalence between January 2003 and June 2023. Data on PenA prevalence, allergy recording methods, healthcare setting, and country income were extracted. This study is registered on PROSPERO (CRD42023437718).
Results:
174 studies from 28 countries were included (18,352 screened). Global PenA prevalence was 9·4% (95% CI 8·4-10·4%). 92% of peer-reviewed publications were from high-income countries(HICs), with 72% from the UK, USA or Australia. HICs had higher PenA prevalence 9·9% (95% CI 8·8-11·0%), compared to middle-income countries (MICs), 4·4% (95% CI 2·8-6·2%), p<0.0001. Primary care data was seldom reported (16% of studies), and the method of allergy recording significantly influenced reported prevalence.
Conclusions:
Studies reporting PenA prevalence are skewed towards HICs and secondary care, with little data from Africa, most of Asia and South America. This highlights an unmet need to broaden epidemiological analysis in under-represented regions.
Insights
Globally, 9.4% of adults are labeled with penicillin allergy (PenA), a condition often misdiagnosed. This prevalence varies significantly by country income, highlighting the need for broader data collection to support penicillin de-labeling initiatives.
Area of Science:
- Clinical Medicine
- Infectious Diseases
- Public Health
Background:
- Penicillin allergy (PenA) labels lead to broad-spectrum antibiotic use, increasing antimicrobial resistance and adverse outcomes.
- Approximately 95% of patients with a PenA label are likely misdiagnosed.
- Penicillin de-labeling programs are emerging but are currently limited in scope.
Purpose of the Study:
- To determine the global prevalence of penicillin allergy (PenA) labels.
- To inform the potential impact and scope of penicillin de-labeling programs worldwide.
Main Methods:
- Systematic review and meta-analysis of adult PenA prevalence studies.
- Inclusion criteria: studies published between January 2003 and June 2023.
- Data extracted: PenA prevalence, allergy recording methods, healthcare setting, country income.
Main Results:
- 174 studies from 28 countries were analyzed, encompassing 18,352 patients.
- Global PenA prevalence was 9.4% (95% CI 8.4-10.4%).
- High-income countries (HICs) reported higher PenA prevalence (9.9%) compared to middle-income countries (MICs) (4.4%).
- Studies were heavily skewed towards HICs (92%) and secondary care settings.
- Allergy recording methods significantly impacted reported prevalence.
Conclusions:
- PenA prevalence data is concentrated in HICs and secondary care, with limited representation from Africa, Asia, and South America.
- There is a critical need for expanded epidemiological research in under-represented global regions.
- Addressing data gaps is essential for effective global penicillin de-labeling strategies.
Related Concept Videos
Allergic Reactions
Allergic Drug Reactions
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Cross-reactivity
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

